This is a preliminary programme. Updates may follow in the coming months.

DAY 1 - Friday 4 December 2026

changes may occur

09:00-10:00 | Industry-sponsored satellite symposium
10:00-10:30 | Break
10:30-10:45 | Official opening

Addy van de Luijtgaarden & André Vis

10:45-11:15 | PCa screening and diagnosis in 2026

Moderation: Derya Tilki

  • PCa screening in 2026 - Roderick van den Bergh
  • PCa diagnosis in 2026 - Emanuele Messina
  • Discussion and Q&A - All
11:15-12:00 | Hormonal recovery & rehabilitation

Moderation: Nick James

  • What do patients need? - Kees Vos
  • TRT: Is it still a taboo in PCa? - Bertrand Tombal
  • Rehabilitation strategies after PCa treatment - Erik van Muilekom
  • Discussion and Q&A - All
12:00-12:30 | Update lecture: Surgery

Moderation: Eva Compérat & Roderick van den Bergh

  • Intraoperative margin assessment: Balancing oncological control and functional outcomes - Rik Somford
  • Discussion and Q&A - All
12:30-13:00 | Update lecture: Individualising mHSPC management: Fine-tuning patient care

Moderation: Gunhild von Amsberg

  • Lecture - Amit Bahl
  • Case discussion and Q&A - Amit Bahl, Alice Bernard-Tessier, Gunhild von Amsberg
13:00-14:00 | Lunch
14:00-15:30 | Case discussion session: High-risk localised and locally advanced prostate cancer

Moderation: Karolien Goffin & Derya Tilki

Panel: Vérane Achard, Amit Bahl, Nick James, Géraldine Pignot, Derya Tilki, Bertrand Tombal, Fabio Turco, Roderick van den Bergh, Jochem van der Voort van Zyp, André Vis

  • Case presentation - Constance Huck, Giovanna Pecoraro, Henning Plage
  • Redefining risk & the impact of PSMA PET imaging - Ken Herrmann
  • Role of ARPI addition to ADT + RT: A reality check - Nick James
  • RT intensification strategies - Vérane Achard
  • Discussion and Q&A - All
15:30-16:00 | Real-world case challenges in localised prostate cancer

Moderation: TBC

  • Focal salvage therapy in radiorecurrent PCa : Lessons from Utrecht - Jochem van der Voort van Zyp
16:00-16:30 | Break
16:30-18:00 | Case discussion session: mHSPC

Moderation: Alice Bernard-Tessier & Rob Jones

Panel: Alice Bernard-Tessier, Maria De Santis, Nick James, Aurelius Omlin, Bertrand Tombal, Addy van de Luijtgaarden, Roderick van den Bergh, Jochem van der Voort van Zyp, André Vis, Ursula Vogl, Gunhild von Amsberg, Thomas Zilli

  • Case presentation - Constance Huck, Giovanna Pecoraro, Henning Plage 
  • From burden to biology: Evolving systemic therapy in mHSPC - Bertrand Tombal 
  • Local control in mHSPC: Defining the role of prostate RT - Jochem van der Voort van Zyp
  • Should everybody receive an ARPI? - André Vis 
  • MDT in mHSPC: Where does the evidence lead us? - Thomas Zilli
  • Discussion and Q&A - All

DAY 2 - Saturday 5 December 2026

changes may occur

08:30-09:30 | Industry-sponsored satellite symposium
09:30-10:00 | Break
10:00-11:00 | APCCC 2026 highlights

Moderation: Silke Gillessen & Aurelius Omlin

  • Introduction - Silke Gillessen & Aurelius Omlin
  • Discussion on APCCC 2026 statements - Panel: Ken Herrmann, Nick James, André Vis, Gunhild von Amsberg
11:00-11:30 | Update lecture: Post-ARPI mCRPC: Biology, biomarkers and management

Moderation: Gunhild von Amsberg 

  • Lecture - Alice Bernard-Tessier 
  • Case discussion and Q&A - Alice Bernard-Tessier & Gunhild von Amsberg
     
11:30-13:00 | Case discussion session: CRPC

Moderation: Addy van de Luijtgaarden & Ursula Vogl

Panel: Amit Bahl, Alice Bernard-Tessier, Silke Gillessen, Rob Jones, Aurelius Omlin, Fabio Turco, Addy van de Luijtgaarden, Ursula Vogl, Gunhild von Amsberg

  • Case presentation - Constance Huck, Giovanna Pecoraro, Henning Plage
  • mCRPC update: What's new and what's coming? - Fabio Turco
  • Sequencing decisions: mCRPC dilemma's - Gunhild von Amsberg
  • ARPI alone or PARPi on top? - Aurelius Omlin
13:00-14:00 | Lunch
14:00-14:30 | Update lecture: Radioligand therapy in clinical practice

Moderation: Silke Gillessen

  • Lecture - Karolien Goffin
  • Discussion and Q&A - Karolien Goffin & Silke Gillessen
     
14:30-15:50 | ESO observatory
  • Welcome and introduction from chairs - Bertrand Tombal & Ursula Vogl
  • The patient's perspective - Giovanni Boniolo
  • The radiation oncologist's perspective - Thomas Zilli
  • The pathologist's perspective - Eva Compérat
  • Nuclear medicine physician's perspective on molecular imaging
  • The urologist's perspective on surgery - Roderick van den Bergh
  • The medical oncologist's perspective - Amit Bahl
  • Panel discussion on the hottest topics in prostate cancer in 2027 - All
15:50-16:00 | Closing remarks

Bertrand Tombal & Roderick van den Bergh

16:00-16:30 | Farewell drink supported by ESO